Tarbox Family Office’s Idexx Laboratories IDXX Stock Holding History

Tarbox Family Office’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16	Closed	-$9K	–	527
2022 Q1	$9K	Sell	16 -8	-33%	-$4.21K	﹤0.01%	398
2021 Q4	$16K	Hold	24	–	–	﹤0.01%	382
2021 Q3	$15K	Hold	24	–	–	﹤0.01%	421
2021 Q2	$15K	Hold	24	–	–	﹤0.01%	420
2021 Q1	$12K	Hold	24	–	–	﹤0.01%	390
2020 Q4	$12K	Buy	24 +3	+14%	+$1.34K	﹤0.01%	376
2020 Q3	$8K	Hold	21	–	–	﹤0.01%	418
2020 Q2	$7K	Buy	21 +10	+91%	+$2.9K	﹤0.01%	435
2020 Q1	$3K	Hold	11	–	–	﹤0.01%	532
2019 Q4	$3K	Buy	11 +5	+83%	+$1.32K	﹤0.01%	668
2019 Q3	$2K	Buy	6 +3	+100%	+$835	﹤0.01%	739
2019 Q2	$1K	Hold	3	–	–	﹤0.01%	953
2019 Q1	$1K	Hold	3	–	–	﹤0.01%	568
2018 Q4	$1K	Buy	+3	New	+$615	﹤0.01%	563

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Tarbox Family Office's IDXX Position: Q2 2022 in Review

Tarbox Family Office sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 16 shares — an estimated $9K sold.

Tarbox Family Office first reported a position in IDXX in Q4 2018 and held it in 14 quarters. The position peaked at $16K in Q4 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Tarbox Family Office reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 16 Idexx Laboratories shares in Q2 2022, an estimated $9K.
Tarbox Family Office first reported a position in Idexx Laboratories in Q4 2018 and held it in 14 quarters.
Tarbox Family Office's Idexx Laboratories position peaked at $16K in Q4 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.